The New York Times reported that the Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for breast cancer after concluding that it “has not been shown to be safe and effective for that use.”
Avastin, made by the pharmaceutical company Roche, will remain an approved treatment for certain types of colon, lung, kidney and brain cancer, the F.D.A. commissioner, Margaret A. Hamburg, announced.
Some women who say the drug has been keeping them alive had pleaded desperately for the approval to be retained.
Read More:
http://www.nytimes.com/?emc=na
